Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thrombosis × Phlebotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 4 Myeloproliferative Disorders 3 Thymic aplasia 1 Thrombosis 1 Smoking 1 Sarcoma 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Metabolic Syndrome 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Insulin Resistance 1 Immunologic Deficiency Syndromes 1 Hyperandrogenism 1 Histiocytoma, Malignant Fibrous 1 Carcinoma, Squamous Cell 1

Interventions

apixaban 4 Enoxaparin 3 Dalteparin 3 Warfarin 2 Rivaroxaban 2 Heparin, Low-Molecular-Weight 2 Aspirin 2 palbociclib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 X-Rays 1 Tinzaparin 1 Technetium Tc 99m Sulfur Colloid 1 Simvastatin 1 Saline Solution 1 Physical Therapy Modalities 1 Photons 1 Phlebotomy 1 Paclitaxel 1 Observation 1 Musculoskeletal Manipulations 1 Injections 1 Hydroxyurea 1 Heparin 1 Fondaparinux 1 Docetaxel 1 Dexmedetomidine 1 Dabigatran 1 Clopidogrel 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡